M Rocco Selected Research

M Rocco Research Topics

Disease

4	Respiratory Insufficiency (Respiratory Failure) 12/2002 - 01/2000
3	Neoplasms (Cancer) 11/2016 - 10/2013
2	Infections 01/2013 - 07/2000
1	Vasculitis (Vasculitides) 11/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Large Granular Lymphocytic Leukemia 11/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2016
1	Hematologic Neoplasms (Hematological Malignancy) 11/2016
1	Sudden Hearing Loss (Sudden Deafness) 10/2015
1	Sensorineural Hearing Loss 10/2015
1	Hearing Loss (Hearing Impairment) 10/2015
1	Hyperoxia 03/2014
1	Hypoxia (Hypoxemia) 03/2014
1	Prostatic Neoplasms (Prostate Cancer) 10/2013
1	Multiple Myeloma 10/2013
1	Bone Resorption 10/2013
1	Neoplasm Metastasis (Metastasis) 10/2013
1	Hematologic Diseases (Blood Diseases) 01/2013
1	Osteoporosis 01/2013
1	Sepsis (Septicemia) 01/2013
1	Necrosis 01/2013
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2012
1	Anemia 11/2011
1	Acute Kidney Injury (Acute Renal Failure) 11/2011
1	Brain Death (Brain Dead) 12/2010
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2010
1	Myocardial Stunning (Stunned Myocardium) 08/2006
1	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 08/2006
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2001
1	Protein-Energy Malnutrition (Marasmus) 04/2001
1	Body Weight (Weight, Body) 04/2001
1	Kidney Diseases (Kidney Disease) 04/2001
1	Thrombosis (Thrombus) 07/2000
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2000
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2000
1	Pathologic Constriction (Stenosis) 07/2000

Drug/Important Bio-Agent (IBA)

4	Oxygen (Dioxygen)IBA 10/2015 - 01/2000
2	CalciumIBA 01/2018 - 08/2006
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Membrane LipidsIBA 01/2018
1	Farnesyltranstransferase (Farnesyltransferase)IBA 11/2016
1	(alpha-hydroxyfarnesyl)phosphonic acidIBA 11/2016
1	Bendamustine Hydrochloride FDA Link 11/2016
1	lonafarnib (SCH 66336)IBA 11/2016
1	manumycinIBA 11/2016
1	SteroidsIBA 10/2015
1	Diphosphonates (Bisphosphonates)IBA 10/2013
1	Zoledronic Acid (Zometa)FDA Link 10/2013
1	PanobinostatIBA 10/2013
1	Histone Deacetylase InhibitorsIBA 10/2013
1	Mevalonic Acid (Mevalonate)IBA 10/2013
1	Penicillins (Penicillin)FDA Link 01/2013
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2012
1	Methotrexate (Mexate)FDA LinkGeneric 01/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012
1	MineralsIBA 11/2011
1	Biomarkers (Surrogate Marker)IBA 11/2011
1	Insulin-Like PeptidesIBA 05/2010
1	Growth Hormone (Somatotropin)IBA 05/2010
1	Simendan (Levosimendan)IBA 08/2006
1	LigandsIBA 08/2001
1	Eptifibatide (Integrilin)FDA Link 08/2001
1	Fibrinogen (Factor I)FDA Link 08/2001
1	IntegrinsIBA 08/2001
1	Serum AlbuminIBA 04/2001
1	AntimetabolitesIBA 07/2000
1	Floxuridine (FUdR)FDA LinkGeneric 07/2000
1	FibrinIBA 07/2000

Therapy/Procedure

4	Therapeutics 11/2018 - 10/2013
2	Artificial Respiration (Mechanical Ventilation) 12/2002 - 07/2000
2	Noninvasive Ventilation 10/2001 - 01/2000
2	Renal Dialysis (Hemodialysis) 04/2001 - 07/2000
1	Hyperbaric Oxygenation 10/2015
1	Hematopoietic Stem Cell Transplantation 01/2013
1	Splenectomy 01/2013
1	Critical Care (Surgical Intensive Care) 11/2011
1	Decompressive Craniectomy 12/2010
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 12/2002
1	Lung Transplantation 10/2001
1	Catheters 07/2000
1	Organ Transplantation 01/2000
1	Transplantation 01/2000